Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 2.0 ?g per million cells in 100 ?l volume. It is recommended that the reagent be titrated for optimal performance for each application.

The 3G8 antibody clone blocks neutrophil phagocytosis and stimulates NK cell proliferation. It has been reported that this clone interacts with the FcγRIIa and FcγRIIIb receptors causing neutrophil activation and aggregation¹⁸. Due to this phenomenon staining in whole blood may cause a reduction in the number of granulocytes or alter their scatter profile.

Additional reported applications (for the relevant formats) include: immunohistochemical staining of acetone-fixed frozen tissue sections⁶, immunoprecipitation³, stimulation of NK cell proliferation⁴, blocking of phagocytosis⁵, and blocking of immunoglobulin binding to FcγRIII^7,8. The Ultra-LEAF? purified antibody (Endotoxin < 0.01 EU/?g, Azide-Free, 0.2 ?m filtered) is recommended for functional assays (Cat. No. 302049, 302050, 302057, 302058).

1. Knapp W, et al. Eds. 1989. Leucocyte Typing IV. Oxford University Press. New York.
2. Schlossman S, et al. Eds. 1995. Leucocyte Typing V. Oxford University Press. New York.
3. Edberg J, et al. 1997. J. Immunol. 159:3849. (IP)
4. Hoshino S, et al. 1991. Blood 78:3232. (Stim)
5. Tamm A, et al. 1996. Immunol. 157:1576. (Block)
6. Da Silva DM, et al. 2001. Int. Immunol. 13:633. (IHC)
7. Holl V, et al. 2004. J. Immunol. 173:6274. (Block)
8. Hober D, et al. 2002. J. Gen. Virol. 83:2169. (Block)
9. Brainard DM, et al. 2009. J. Virol. 83:7305. PubMed
10. Smed-S?rensen A, et al. 2008. Blood 111:5037. (Block) PubMed
11. Timmerman KL, et al. 2008. J. Leukoc. Biol. 84:1271. (FC) PubMed
12. Yoshino N, et al. 2000. Exp. Anim. (Tokyo) 49:97. (FC)
13. Rout N, et al. 2010. PLoS One 5:e9787. (FC)
14. Kim WK, et al. 2006. Am. J. Pathol. 168:822. (FC)
15. Boltz A, et al. 2011. J. Biol Chem. 286:21896. PubMed
16. Wu Z, et al. 2013. J. Virol. 87:7717. PubMed
17. Peterson VM, et al. 2017. Nat. Biotechnol. 35:936. (PG)
18. Vossebeld PJ, et al. 1997. Biochem J. 323:87-94 (Stim)

1. Dallari S, et al. 2017. Nat Commun. 8:14830. PubMed
2. Weinhage T, et al. 2020. J Immunol. 205:56. PubMed
3. Miyamoto DT, et al. 2018. Cancer Discov. 0.533333333. PubMed
4. Korn MA, et al. 2020. J Immunol. 205:2595. PubMed
5. Friedman D, et al. 2021. J Cell Sci. 134:. PubMed
6. Wu Z, et al. 2013. J Virol. 87:7717. PubMed
7. Wagner J et al. 2019. Cell. 177(5):1330-1345 . PubMed
8. Holder KA, et al. 2021. Clin Transl Immunology. 10:e1348. PubMed
9. Smed-S?rensen A, et al. 2008. Blood. 111:5037. PubMed
10. Cao Q, et al. 2018. Am J Physiol Renal Physiol. 314:F561. PubMed
11. Fasbender F, et al. 2017. Front Immunol. 0.88125. PubMed
12. Mask E, et al. 2022. Front Cell Infect Microbiol. 12:880860. PubMed
13. Santos R, et al. 2017. Nat Commun. . 10.1038/s41467-017-01760-5. PubMed
14. Alcántara-Hernández M, et al. 2021. Nat Protoc. 16:4855. PubMed
15. Mann ER, et al. 2020. Sci Immunol. :5. PubMed
16. Boltz A, et al. 2011. J Biol Chem. 286:21896. PubMed
17. Winkler M, et al. 2017. PLoS One.. 10.1371/journal.pone.0182427. PubMed
18. Li L, et al. 2019. Cell Stem Cell. 24:271. PubMed
19. Gainers M, et al. 2007. J Immunol. 179:8509. PubMed
20. Sibener LV et al. 2018. Cell. 174(3):672-687 . PubMed
21. Syrimi E, et al. 2021. iScience. 24:103215. PubMed
22. Okubo K, et al. 2021. Cell Reports. 35(7):109142. PubMed
23. Urlaub D, et al. 2017. J Immunol. 198:1944. PubMed
24. Jog NR, et al. 2018. Front Immunol. 9:2198. PubMed
25. Eldredge LC, et al. 2019. Am J Physiol Lung Cell Mol Physiol. 317:L49. PubMed
26. Olin A, et al. 2018. Cell. 174:1277. PubMed
27. Farhadian SF, et al. 2022. JCI Insight. 7:. PubMed
28. Park YJ, et al. 2022. PLoS Pathog. 18:e1010468. PubMed
29. Park JE, et al. 2020. Journal for ImmunoTherapy of Cancer. 8(2):e000873.. PubMed
30. Auladell M, et al. 2019. Clin Transl Immunology. 8:e01090. PubMed
31. Eccles JD, et al. 2020. Cell Rep. 30:351. PubMed
32. Prodjinotho UF, et al. 2017. PLoS Negl Trop Dis. 11:e0005777. PubMed
33. Ehinger E, et al. 2021. Cardiovasc Res. 117:1166. PubMed
34. Frobel J, et al. 2018. Clin Epigenetics. 10:67. PubMed
35. Li J, et al. 2021. Haematologica. 106:3115. PubMed
36. Shemesh A, et al. 2022. J Exp Med. 219:. PubMed
37. Kato M, et al. 2021. PLoS One. 16:e0252116. PubMed
38. Combes AJ, et al. 2021. Nature. 591:124. PubMed
39. Mody P, et al. 2007. Blood. 110:2974. PubMed
40. Ardain A, et al. 2019. Nature. 570:528. PubMed
41. Doni A, et al. 2021. Nat Commun. 12:3739. PubMed
42. Steffen U, et al. 2020. Nat Commun. 0.541666667. PubMed
43. Boutboul D, et al. 2018. J Clin Invest. 128:3071. PubMed
44. Pohl K, et al. 2018. PLoS One. 13:e0209026. PubMed
45. Farrington LA, et al. 2020. PLoS Pathog. 16:e1008997. PubMed
46. De Maeyer RPH, et al. 2020. Nat Immunol. 21:615. PubMed
47. Ravindran A, et al. 2018. Front Immunol. 9:2193. PubMed
48. Edri-Brami M, et al. 2012. PLoS One. 7:e35772. PubMed
49. Lakshmikanth T, et al. 2020. Cell Reports. 32(3):107923. PubMed
50. Chevrier S, et al. 2021. Cell Reports Medicine. 2(1):100166. PubMed
51. Sung JA, et al. 2018. Mol Ther. 26:2496. PubMed
52. Ravell JC, et al. 2020. J Clin Invest. 130:507. PubMed
53. Chevrier S, et al. 2018. Cell Syst. 0.675. PubMed
54. Zhong Q, et al. 2018. J Immunol. 200:3913. PubMed
55. Martin E, et al. 2020. JCI Insight. :5. PubMed
56. Lavin Y et al. 2017. Cell. 169(4):750-765 . PubMed
57. Dutertre CA, et al. 2020. Immunity. 51(3):573-589.e8.. PubMed

NK cells, activated monocytes, macrophages, neutrophils

1. Fleit H, et al. 1982. P. Natl. Acad. Sci. USA 79:3275.
2. Stroncek D, et al. 1991. Blood 77:1572.
3. Wirthmueller U, et al. 1992. J. Exp. Med. 175:1381.